Trump signs order fast tracking review of psychedelics for mental health disorders
President Donald Trump signed an executive order aimed at expanding access to psychedelic drugs for treating mental health conditions like depression and anxiety. The order directs $50 million in federal funding and instructs the Food and Drug Administration to fast-track reviews of substances such as psilocybin and ibogaine. Officials said the goal is to address rising mental health issues, including suicide and severe depression, affecting millions of Americans. The … Continue reading Trump signs order fast tracking review of psychedelics for mental health disorders
